GLAB fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Gemina Laboratories Ltd. engages in the development of a platform for detecting pathogens that affect humans and animals. It focuses on the development of novel surface functionalization chemistries for the detection of pathogens and biomarkers. The company was founded by John Davies on October 10, 2017 and is headquartered in Vancouver, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
GLAB has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company